Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Post by donmayneon May 27, 2021 7:37am
146 Views
Post# 33274004

My email to OIG

My email to OIG
Dear OIG

Below is the text of an online submission that I made to the Department of Justice concerning a troubling report issued by the OIG.
 
"I recently read a report from the Office of the Inspector General that will cause people witih COPD to die and their health care costs to rise.  The report was conducted from the lens of a financial audit but fails to appreciate a significant shift in medical knowledge about the benefits of non-invasive ventilators (NIV).  The report concluded that there was overbilling as a result of the use of NIVs. At this point, the report could have taken two approaches.  it could have looked at medical evidence and decided that CMS billing codes should be revised or that an independent medical study about the benefits of NIVs should be conducted.  Instead it simply extrapolated its accounting conclusion to all billings and to seek the loudest headline.  People will die as a result of the setbacks to the positive shift in medical treatment of COPD.  In addition the report will force more people with COPD back into costly hospital treatment rather than being treated at home by health professionals.  The OIG (Amy J. Frontz Deputy Inspector General for Audit Services) sought headlines instead of the more responsible route of seeking adjustments in CMS billing codes.  The report does include the response of the audited company but the OIG preferred the headline grabbing route rather than the medically responsible route of taking their findings and working with CMS to adjust its billing codes in light of shifting medical knowledge favoring NIVs.  This report will cause people to die and health care costs to rise.  This is not the professionalism that I want from the OIG."
<< Previous
Bullboard Posts
Next >>